4-Fluorotetrahydro-2H-pyran-4-carboxylic acid, 95.0%, 1g

1,1,3,3-Tetramethyldisilazane, 95%, 25g

(S)-1-N-Boc-3-Cyano-piperidine, 97.0%, 25g

2-((2S,3S)-3-(tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)-6-methoxypyridine, 97%, 100mg

8-(BENZYLOXY)-2-METHOXYQUINOLINE, 95.0%, 1g

ETHYL 1-(2-(ETHOXYCARBONYL)PHENYL)PIPERIDINE-4-CARBOXYLATE, 95.0%, 1g

[2-(methoxymethoxy)phenyl](pyridin-2-yl)methanone, 95.0%, 1g

1-(Aminomethyl)cyclohexan-1-ol hydrochloride, 97%, 5g

(2-Fluoro-6-iodophenyl)boronic acid, 95.0%, 1g

(R)-Pyrrolidin-3-yl-carbamic acid benzyl ester hydrochloride, 95.0%, 250mg

6,7,8,9-Tetrahydro-5H-Imidazo[1,2-A][1,4]Diazepine Hydrochloride, 95%, 250mg

2-(TRIFLUOROMETHYL)QUINOLINE-5-CARBOXYLIC ACID, 95%, 250mg

Objectif IOS plan PL 10x/0,25 corrigé à l'infini. Distance de travail 12,1 mm